Ethyl 3-methylpyrazine-2-carboxylate

Catalog No. :
ACSCIO831
CAS No. :
25513-92-2
Molecular Formula :
C8H10N2O2
Molecular Weight :
166.18

IUPAC Name:ethyl 3-methylpyrazine-2-carboxylate

Ethyl 3-methylpyrazine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$132.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-methylpyrazine-2-carboxylate
IUPAC Nameethyl 3-methylpyrazine-2-carboxylate
MDL No.MFCD09839066
Molecular FormulaC8H10N2O2
Molecular Weight166.18
SMILESO=C(C1=NC=CN=C1C)OCC
InChI KeyOZDZUPFOJNCJNW-UHFFFAOYSA-N
Synonym3-methyl-pyrazine-2-carboxylic acid ethyl ester | 3-Methylpyrazine-2-carboxylic acid ethyl ester | SCHEMBL750492 | DTXSID80474407 | 3-methylpyrazine-2-carboxylate | ETHYL3-METHYLPYRAZINE-2-CARBOXYLATE | CS-0151839 | AKOS006328556 | MFCD09839066 | FT-07251
CAS No.25513-92-2
PubChem CID11850912

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACSCIO831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACPQNZ607 route compound structure diagram
    ACPQNZ60741110-28-5 In Stock
  4. Then
  5. ACSCIO831 route product structure diagram
    ACSCIO83125513-92-2 In Stock
Inquiry

2. ACSCIO831 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACPQNZ607 route compound structure diagram
    ACPQNZ60741110-28-5 In Stock
  4. Plus
  5. ACDTQJ324 route compound structure diagram
    ACDTQJ3247447-41-8 In Stock
  6. Then
  7. ACSCIO831 route product structure diagram
    ACSCIO83125513-92-2 In Stock
Inquiry

Comments (0)